Smitvi Smitvi
Risultati di ricerca
Mostra tutti i risultati
  • Iscriviti
    Registrati
    Iscriviti
    Cerca

Cerca

Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie

  • Notizie
  • Competitions
    • All Competitions
    • My Competitions
    • • Active
    • • Past
    • • Won
  • EXPLORE
  • Gruppi
  • Blogs
  • Jobs
  • Courses
  • Articoli
  • Blogs
  • Utenti
  • Gruppi
  • Subodh Adke ha aggiunto una foto Altre informazioni
    2026-05-05 11:48:33 -
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period.  (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....
    0 Commenti 0 condivisioni 79 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Subhayan Mayra ha aggiunto una foto Altre informazioni
    2026-04-15 11:50:17 -
    Brigatinib API Market Growing at 8.1% CAGR Through 2034 Globally
    According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
    0 Commenti 0 condivisioni 440 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Subhayan Mayra ha aggiunto una foto Altre informazioni
    2026-04-20 11:24:45 -
    Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
    According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
    0 Commenti 0 condivisioni 398 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
© 2026 Smitvi Italiano
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Contact Disclaimer About Terms & Conditions Privacy Contattaci Elenco